Biotechnology News and Research

RSS

Potential method for repairing misspelling in DNA code that causes spinal muscular atrophy

Researchers at the University of Delaware have discovered a novel technique - that acts like a "spell-checker" for correcting a misspelling in the DNA code - to repair the defective gene that causes spinal muscular atrophy (SMA).

12 Feb 2008

Funding boost for research into epilepsy and hearing loss

Two research projects at the University of Bristol have been awarded over £600,000 in total, to help provide greater understanding of epilepsy, the most common serious primary brain disorder in the UK

11 Feb 2008

Revelation of new genes linked to prostate cancer could single out high risk men

The discovery by researchers of at least ten new genes associated with prostate cancer could in future be used to accurately identify high-risk men.

11 Feb 2008

Respiration device for detecting early-stage respiratory irregularities in premature babies

A start-up company is developing a novel, non-invasive device for detecting early-stage respiratory irregularities in premature babies, children and adults receiving ICU care.

8 Feb 2008

Scientists create fluorescent proteins for live cell imaging, biosensor design

Scientists at Carnegie Mellon University's Molecular Biosensor and Imaging Center have developed new "fluorogen activating proteins" (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon.

7 Feb 2008

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those who received standard treatment combined with placebo.

4 Feb 2008

USA Today examines possible reasons for five-year low of FDA drug approval rate

USA Today on Monday examined how some pharmaceutical industry analysts cite "more cautious regulators and less innovation by drug makers" as reasons for the low rate of new drug approvals in 2007 (Schmit, USA Today, 2/4).

4 Feb 2008

Novel wound-healing peptide gel

First-String Research, Inc. (FSR), a spin-off biotechnology company from the Medical University of South Carolina (MUSC), has begun the human clinical trial process for its unique, wound-healing peptide gel.

4 Feb 2008

MUSC spin-off to test wound-healing peptide gel

30 Jan 2008

E.coli tweaked to produce hydrogen

For most people, the name "E. coli" is synonymous with food poisoning and product recalls, but a professor in Texas A&M University's chemical engineering department envisions the bacteria as a future source of energy, helping to power our cars, homes and more.

30 Jan 2008

Engineers use blood's hydrodynamics to manipulate stem, cancer cells

A tiny, implantable device has pulled adult stem cells out of a living rat with a far greater purity than any present technique.

24 Jan 2008

Unique fungal collection could hold key to future antibiotics

Scientists at Royal Holloway, University of London have joined forces with CABI to establish a facility to screen for potential new antibiotics.

23 Jan 2008

Gold nanoparticles shine brightly in tumors

Solid gold nanoparticles have long been used to treat rheumatoid arthritis and more recently have shown promise in treating various types of cancer.

16 Jan 2008

Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer

As the incidence of liver cancer continues to grow - fueled in large part, by rising rates of hepatitis C infections - so too does the need for tests to help diagnose the disease at an earlier stage.

16 Jan 2008

Biotechnology Industry Organization supports FDA's safety conclusions on animal cloning

Biotechnology Industry Organization (BIO) President and Chief Executive Officer Jim Greenwood today issued the following statement in response to a risk assessment published today by the U.S. Food and Drug Administration (FDA) regarding the safety of milk and meat products from cloned animals and their offspring:

15 Jan 2008

Potential new treatment for inflammatory bowel disease

Irish scientists have discovered a new potential therapeutic approach to Inflammatory Bowel Disease (IBD), a chronic debilitating disease involving inflammation of the intestine which affects more than 15,000 people in Ireland and millions of people worldwide.

15 Jan 2008